William T. Chance
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
William T. Chance has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
Ramesh Dayal
Research Service, Veterans Affairs Medical Center
6 shared publicationsSulaiman Sheriff
University Of Cincinnati Medical Center
6 shared publicationsLou Ann Friend
University Of Cincinnati Medical Center
5 shared publicationsIngrid Thomas
University Of Cincinnati Medical Center
3 shared publicationsAmbikaipakan Balasubramaniam
Department of Surgery, University of Cincinnati Medical Center, Cincinnati, OH, USA
2 shared publicationsChun Xiao
University of Cincinnati
1 shared publication
Latest Publications
- 28 December 2007
- Published by Taylor & Francis in Nutrition and Cancer
- Vol. 60 (1) , 75-90
Continuous Intravenous Infusion of Ghrelin Does Not Stimulate Feeding in Tumor-Bearing Rats
The development of anorexia continues to be a serious treatment issue for cancer patients. Because the orexigenic peptide, ghrelin, is active through systemic routes and activates hypothalamic neuropeptide systems known to be refractory in anorectic tumor-bearing (TB) rats, we investigated whether it would prevent the development of cancer anorexia when infused continuously intravenously. The 24-h food intake was increased in nontumor-bearing (NTB) rats at a dose of 288 ug/day ghrelin. However, no tested dose of ghrelin, up to 576 ug/day, elicited increased feeding in TB rats prior to or subsequent to the development of anorexia. In hypothalamus, ghrelin-infused TB rats exhibited significantly increased concentration of neuropeptide Y (NPY) as compared to saline-infused TB rats. Hypothalamic expression of NPY and agouti-related protein (AgRP) messenger RNA were elevated in ghrelin-infused TB rats as compared to NTB rats, but saline-infused TB rats also exhibited increased expression of AgRP. Proopiomelanocortin message was reduced in ghrelin-infused and saline-infused TB rats as compared to noninfused TB control rats. Although ghrelin infusion did not preserve muscle protein, a significant saving in body fat was observed in TB rats. Thus, the adiposity effects of ghrelin did not require an orexigenic response to the peptide. These results suggest that continuous ghrelin infusion may not be an effective treatment for cancer anorexia.
- 28 December 2007
- Published by Taylor & Francis in Nutrition and Cancer
- Vol. 60 (1) , 75-90
Continuous Intravenous Infusion of Ghrelin Does Not Stimulate Feeding in Tumor-Bearing Rats
The development of anorexia continues to be a serious treatment issue for cancer patients. Because the orexigenic peptide, ghrelin, is active through systemic routes and activates hypothalamic neuropeptide systems known to be refractory in anorectic tumor-bearing (TB) rats, we investigated whether it would prevent the development of cancer anorexia when infused continuously intravenously. The 24-h food intake was increased in nontumor-bearing (NTB) rats at a dose of 288 ug/day ghrelin. However, no tested dose of ghrelin, up to 576 ug/day, elicited increased feeding in TB rats prior to or subsequent to the development of anorexia. In hypothalamus, ghrelin-infused TB rats exhibited significantly increased concentration of neuropeptide Y (NPY) as compared to saline-infused TB rats. Hypothalamic expression of NPY and agouti-related protein (AgRP) messenger RNA were elevated in ghrelin-infused TB rats as compared to NTB rats, but saline-infused TB rats also exhibited increased expression of AgRP. Proopiomelanocortin message was reduced in ghrelin-infused and saline-infused TB rats as compared to noninfused TB control rats. Although ghrelin infusion did not preserve muscle protein, a significant saving in body fat was observed in TB rats. Thus, the adiposity effects of ghrelin did not require an orexigenic response to the peptide. These results suggest that continuous ghrelin infusion may not be an effective treatment for cancer anorexia.
- 20 February 2007
- Published by Elsevier in Life Sciences
- Vol. 80 (11) , 1064-1072
Mediation of burn-induced hypermetabolism by CRF receptor-2 activity
- 20 February 2007
- Published by Elsevier in Life Sciences
- Vol. 80 (11) , 1064-1072
Mediation of burn-induced hypermetabolism by CRF receptor-2 activity
- 1 January 2006
- Published by Elsevier in Life Sciences
- Vol. 78 (7) , 694-703
Possible role of CRF peptides in burn-induced hypermetabolism
- 1 January 2006
- Published by Elsevier in Life Sciences
- Vol. 78 (7) , 694-703
Possible role of CRF peptides in burn-induced hypermetabolism
- 1 March 2004
- Published by Taylor & Francis in Nutrition and Cancer
- Vol. 48 (2) , 174-181
Elevated Blood Lactate Is Not a Primary Cause of Anorexia in Tumor-Bearing Rats
Tumor-bearing (TB) rats exhibit elevated concentrations of lactate in blood contiguous with the development of anorexia. Continuous intravenous infusion of lactate into non-TB rats reduced food intake at plasma concentrations lower than those observed in anorectic TB rats. Levels of neuropeptide Y (NPY) were elevated in the ventromedial (VMH) and dorsomedial hypothalamic regions of lactate-infused rats. The addition of the enhancer of pyruvate dehydrogenase activity, dichloroacetate (DCA), to the drinking water of TB rats (0.1-0.4%) normalized blood lactate concentration but had no significant effect on anorexia. However, the elevated concentration of NPY in the VMH of anorectic TB rats was also normalized by the DCA treatment. No alterations in regional hypothalamic levels of corticotropin-releasing factor were observed within any treatment conditions. These results suggest that, although hyperlactatemia may be involved in maintaining elevated NPY concentrations in anorectic TB rats, it does not appear t...
- 1 March 2004
- Published by Taylor & Francis in Nutrition and Cancer
- Vol. 48 (2) , 174-181
Elevated Blood Lactate Is Not a Primary Cause of Anorexia in Tumor-Bearing Rats
Tumor-bearing (TB) rats exhibit elevated concentrations of lactate in blood contiguous with the development of anorexia. Continuous intravenous infusion of lactate into non-TB rats reduced food intake at plasma concentrations lower than those observed in anorectic TB rats. Levels of neuropeptide Y (NPY) were elevated in the ventromedial (VMH) and dorsomedial hypothalamic regions of lactate-infused rats. The addition of the enhancer of pyruvate dehydrogenase activity, dichloroacetate (DCA), to the drinking water of TB rats (0.1-0.4%) normalized blood lactate concentration but had no significant effect on anorexia. However, the elevated concentration of NPY in the VMH of anorectic TB rats was also normalized by the DCA treatment. No alterations in regional hypothalamic levels of corticotropin-releasing factor were observed within any treatment conditions. These results suggest that, although hyperlactatemia may be involved in maintaining elevated NPY concentrations in anorectic TB rats, it does not appear t...